Long-term safety data are still being collected
This may help regulate hormones in conditions like insulin resistance or PCOS, but it is not a hormone therapy and does not directly balance estrogen or progesterone
1, 2023, Pfizer discontinued its mid-stage trials of danuglipron due to dropouts driven by high rates of side effects, including vomiting and nausea
Mostly, thats the topic for today
Ready to Lose Weight with Semaglutide from Dr
Some are approved to lower heart disease risk, and the FDA has cleared semaglutide to reduce the risk of heart attack, stroke, and cardiovascular death in adults with established heart disease and either obesity or overweight, a milestone first reported through the landmark SELECT trial summarized by Yale Medicine